Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - Paul LaViolette to serve as Co-Chairman alongside Robert W. Duggan, adding 40 years of medical technology development, operating and leadership expertise
Spineology® Announces $25 Million Equity Financing – Funding to aid in acceleration of commercial growth, clinical education programs, and product development enhancements for highly-differentiated OptiMesh® implant portfolio –
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure
Merck signs $3bn deal for Kate Bingham-backed eye disease biotechRead More
SV Health Investors-created EyeBio to be acquired by MSD for up to $3 billion
Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
SV News
- 24 July 2024Portfolio NewsEdwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
- 15 May 2024Portfolio NewsBrixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
- 20 December 2023Portfolio NewsPerfuze® Announces FDA Clearances for Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment
- 2 November 2023Portfolio NewsPerfuze Announces First Stroke Patient Enrolled in the MARRS Pivotal Clinical Trial for the Millipede System
- 1 November 2023Portfolio NewsVibrato Medical Announces Positive Results for Early Feasibility Study of Wearable, Non-Invasive Therapeutic Ultrasound to Treat Chronic Limb-Threatening Ischemia
- 17 July 2023Portfolio NewsAI-Enabled Senior Care Company CarePredict Scores $29M
- 12 January 2023Portfolio NewsFeinstein Institutes, Northwell Use Ultrasound to Treat Brain Tumors in Novel Clinical Trial
- 6 December 2022Portfolio NewsAlison Burkland, co-founder of MCF portfolio company Nanopath, has been named one of Forbes' 30 under 30
- 10 October 2022Portfolio NewsAmogha Tamidety focuses on 'underserved' field of women's health
- 8 September 2022Portfolio NewsArtemis Health and Zerigo Health Announce Partnership to Help Employers and Health Plans Better Evaluate and Manage Chronic Autoimmune Skin Conditions
- 17 August 2022Portfolio NewsPodimetrics Declares War on Diabetic Foot Amputations
- 9 August 2022Portfolio NewsNanopath Secures $10 Million in Series A Funding to Develop and Commercialize Point-of-Care Diagnostics for Women's Health